| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
227,123 |
195,985 |
$9.56M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
107,006 |
96,565 |
$6.87M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
38,892 |
35,627 |
$2.55M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
34,774 |
31,369 |
$2.09M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
27,609 |
25,665 |
$1.79M |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
101,007 |
91,998 |
$1.32M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
17,566 |
16,120 |
$1.23M |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
65,835 |
60,343 |
$900K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
34,730 |
31,394 |
$864K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
22,506 |
19,086 |
$661K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
48,408 |
23,822 |
$490K |
| 92552 |
|
27,775 |
24,834 |
$362K |
| 99215 |
Prolong outpt/office vis |
4,012 |
3,738 |
$349K |
| 98960 |
|
3,807 |
2,646 |
$296K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
20,407 |
17,003 |
$201K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,858 |
2,389 |
$198K |
| 92551 |
|
16,632 |
15,525 |
$126K |
| 90474 |
|
12,715 |
11,875 |
$109K |
| 99381 |
|
1,462 |
1,343 |
$99K |
| 99173 |
|
49,141 |
44,551 |
$82K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
20,339 |
16,734 |
$81K |
| 83655 |
|
8,644 |
7,173 |
$77K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,852 |
1,615 |
$77K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
691 |
641 |
$75K |
| 99051 |
|
4,263 |
3,876 |
$68K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,266 |
1,226 |
$67K |
| 99460 |
|
1,212 |
1,175 |
$56K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
625 |
555 |
$41K |
| 87807 |
|
3,834 |
3,192 |
$39K |
| 85018 |
|
21,516 |
18,039 |
$37K |
| 87428 |
|
1,876 |
1,644 |
$35K |
| 99205 |
Prolong outpt/office vis |
133 |
123 |
$16K |
| 96161 |
|
3,770 |
3,032 |
$14K |
| 99188 |
|
650 |
538 |
$12K |
| 99383 |
|
148 |
139 |
$11K |
| 99401 |
|
657 |
489 |
$10K |
| 99219 |
|
102 |
99 |
$8K |
| 81002 |
|
3,794 |
3,363 |
$8K |
| 99050 |
|
611 |
581 |
$8K |
| 99384 |
|
78 |
72 |
$7K |
| 99462 |
|
264 |
198 |
$6K |
| 96127 |
|
7,933 |
6,338 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
537 |
465 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
56 |
51 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
260 |
223 |
$2K |
| 99441 |
|
149 |
149 |
$2K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
15 |
13 |
$1K |
| 86318 |
|
62 |
55 |
$698.46 |
| 96380 |
|
48 |
40 |
$571.28 |
| 99442 |
|
199 |
180 |
$277.92 |
| 81025 |
|
72 |
54 |
$267.65 |
| 90651 |
|
8,344 |
7,315 |
$242.75 |
| 90670 |
|
24,559 |
22,617 |
$198.00 |
| 90677 |
|
2,027 |
1,812 |
$165.03 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
93 |
86 |
$163.70 |
| 90698 |
|
20,053 |
18,797 |
$137.00 |
| 36416 |
|
5,589 |
4,769 |
$53.74 |
| 94760 |
|
198 |
114 |
$39.94 |
| 90715 |
|
2,018 |
1,801 |
$31.44 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
489 |
403 |
$25.71 |
| 90686 |
|
12,696 |
11,767 |
$19.03 |
| 90656 |
|
172 |
144 |
$6.25 |
| 90633 |
|
15,251 |
13,617 |
$0.08 |
| 90734 |
|
3,352 |
3,109 |
$0.00 |
| 90710 |
|
2,149 |
1,879 |
$0.00 |
| 90621 |
|
1,575 |
1,342 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,812 |
1,441 |
$0.00 |
| 90707 |
|
698 |
634 |
$0.00 |
| 90648 |
|
341 |
322 |
$0.00 |
| 90700 |
|
322 |
298 |
$0.00 |
| 90671 |
|
514 |
314 |
$0.00 |
| 90685 |
|
128 |
124 |
$0.00 |
| H2020 |
Therapeutic behavioral services, per diem |
168 |
86 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
62 |
42 |
$0.00 |
| 90681 |
|
16 |
15 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
27 |
13 |
$0.00 |
| 90680 |
|
12,534 |
11,663 |
$0.00 |
| 90744 |
|
8,249 |
7,810 |
$0.00 |
| 90697 |
|
2,368 |
1,883 |
$0.00 |
| 90696 |
|
1,528 |
1,344 |
$0.00 |
| 90619 |
|
3,133 |
2,554 |
$0.00 |
| 90723 |
|
118 |
116 |
$0.00 |
| 90716 |
|
775 |
694 |
$0.00 |
| 99070 |
|
41 |
34 |
$0.00 |